Back to Trades
Sell4
Medline Inc.
MDLN
Total Value
$1.1B
Net $1.1B sold
Sales
$1.1B
4 transactions
Company Information
- Company Name
- Medline Inc.
- Ticker Symbol
- MDLN
- CIK
- 0002046386
Insider Information
- Role
- Insider
- Location
- SAN FRANCISCO, CA
Filing Details
- Filing Date
- Mar 12, 2026
- Transaction Date
- Mar 10, 2026
- Accession Number
- 0001193125-26-104678
- Form Type
- 4
- Net Trading Amount
- -$1.1B
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Class A Common Stock | 14,639,754 | $40.51 | Sale | $593.0M |
| Mar 10, 2026 | Class A Common Stock | 629,933 | $40.51 | Sale | $25.5M |
| Mar 10, 2026 | Class A Common Stock | 9,801,455 | $40.51 | Sale | $397.0M |
| Mar 10, 2026 | Class A Common Stock | 1,060,095 | $40.51 | Sale | $42.9M |
| Mar 10, 2026 | Class A Common Stock | 538,997 | — | Other | — |
| Mar 10, 2026 | Class A Common Stock | 1,435,395 | — | Other | — |
| Mar 10, 2026 | Class A Common Stock | 113,694 | — | Other | — |
Footnotes
- (F1)This amount represents the $41.00 secondary public offering price per share of Class A common stock ("Class A Common Stock") of Medline Inc. (the "Issuer"), less the underwriting discount of $0.492 per share sold by the Reporting Persons in connection with an underwritten public offering.
- (F2)Hellman & Friedman Investors X, L.P. ("Investors X GP") is the general partner of Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel - A), L.P. Mend Partners GP, LLC ("Mend GP") is the general partner of Mend Partners II, L.P. Investors X GP is the managing member of Mend GP. Mend Investment Holdings GP, LLC ("Mend Investment GP") is the general partner of Mend Investment Holdings I, L.P. Hellman & Friedman Capital Partners X, L.P. ("HFCP X") is the managing member of Mend Investment GP. Investors X GP is the general partner of HFCP X. H&F Corporate Investors X, Ltd. ("Investors X Ltd.") is the general partner of Investors X GP.
- (F3)(Continued from footnote 2) A three-member board of directors of Investors X Ltd. has voting and investment discretion over the securities held by Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), Mend Partners II, L.P., and Mend Investment Holdings I, L.P. Each of the members of the board of directors of Investors X Ltd. disclaims beneficial ownership of such shares.
- (F4)On March 10, 2026, Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel - A), L.P. contributed shares of Class A common stock to certain of their respective wholly owned subsidiaries, which subsidiaries immediately sold such shares in the underwritten public offering referred to above.
- (F5)On March 10, 2026, in connection with the sales reported above, each of Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), L.P., and Mend Investment Holdings I, L.P. initiated distributions of shares of Class A Common Stock to their respective ultimate partners and shareholders as in-kind distributions in respect of such persons' interests in the distributing entities. The receipt of shares of Class A Common Stock by each of the Reporting Persons in connection with such distributions was exempt from reporting pursuant to Rule 16a-13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").
- (F6)The recipients of the shares of Class A Common Stock distributed pursuant to footnote 5 have agreed to be subject to a lock-up agreement with the representatives of the several underwriters in connection with the underwritten public offering of the Issuer referred to above, provided that shares constituting less than 1% of the Issuer's outstanding common stock in the aggregate that are being delivered to charitable organizations will not be subject to such restrictions.